Table 6 Correlation between the entity of reduction of MPO-DNA complexes and main anthropometric and glyco-metabolic parameters after sleeve gastrectomy.

From: Increased plasmatic NETs by-products in patients in severe obesity

Variation of

Correlation coefficient

respect to MPO-DNA complexes (ρ)

p

Weight (Kg)

0.345

<0.05

Body mass index (Kg/m2)

0.416

<0.05

Waist circumference (cm)

0.245

0.17

Hip circumference (cm)

0.271

0.156

Visceral fat area (cm2)

0.351

<0.05

Fat mass (kg)

0.227

0.072

Fat-free mass (kg)

−0.095

0.455

Glycemia (mg/dL)

0.495

<0.001

Insulinemia (μIU/mL)

0.136

0.473

HOMA-IR

0.212

0.260

Tryglicerides (mg/dL)

−0.045

0.806

Cholesterol (mg/dL)

−0.146

0.418

LDL-c (mg/dL)

−0.09

0.635

HDL-c (mg/dL)

0.097

0.605

ApoA-1 (mg/dL)

−0.379

0.082

ApoB (mg/dL)

0.047

0.834

hs-CRP (µg/mL)

−0.149

0.497

  1. HOMA-IR, homeostasis model assessment for Insulin Resistance; LDL-c: low-density lipoprotein-cholesterol; HDL-c: high-density lipoprotein-cholesterol; ApoA-1: Apolipoprotein A1; ApoB: Apolipoprotein B; hs-CRP: high-sensitivity C-reactive protein. Correlations were determined by Spearman rank test in 73 obese patients.